(1)
Intradermal Immunotherapy With Low-Dose House Dust Mite Allergens in Patients With Allergic Rhinitis: A Proof-of-Concept Study. Rev Alerg Mex 2018, 65 (1), 41-51. https://doi.org/10.29262/ram.v65i1.322.